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Abstract
Background: In the traditional asthma management protocol, a child meets with a clinician infrequently, once in 3 to 6 months,
and is assessed using the Asthma Control Test questionnaire. This information is inadequate for timely determination of asthma
control, compliance, precise diagnosis of the cause, and assessing the effectiveness of the treatment plan. The continuous monitoring
and improved tracking of the child’s symptoms, activities, sleep, and treatment adherence can allow precise determination of
asthma triggers and a reliable assessment of medication compliance and effectiveness. Digital phenotyping refers to
moment-by-moment quantification of the individual-level human phenotype in situ using data from personal digital devices, in
particular, mobile phones. The kHealth kit consists of a mobile app, provided on an Android tablet, that asks timely and contextually
relevant questions related to asthma symptoms, medication intake, reduced activity because of symptoms, and nighttime awakenings;
a Fitbit to monitor activity and sleep; a Microlife Peak Flow Meter to monitor the peak expiratory flow and forced exhaled volume
in 1 second; and a Foobot to monitor indoor air quality. The kHealth cloud stores personal health data and environmental data
collected using Web services. The kHealth Dashboard interactively visualizes the collected data.
Objective: The objective of this study was to discuss the usability and feasibility of collecting clinically relevant data to help
clinicians diagnose or intervene in a child’s care plan by using the kHealth system for continuous and comprehensive monitoring
of child’s symptoms, activity, sleep pattern, environmental triggers, and compliance. The kHealth system helps in deriving
actionable insights to help manage asthma at both the personal and cohort levels. The Digital Phenotype Score and Controller
Compliance Score introduced in the study are the basis of ongoing work on addressing personalized asthma care and answer
questions such as, “How can I help my child better adhere to care instructions and reduce future exacerbation?”
Methods: The Digital Phenotype Score and Controller Compliance Score summarize the child’s condition from the data collected
using the kHealth kit to provide actionable insights. The Digital Phenotype Score formalizes the asthma control level using data
about symptoms, rescue medication usage, activity level, and sleep pattern. The Compliance Score captures how well the child
is complying with the treatment protocol. We monitored and analyzed data for 95 children, each recruited for a 1- or 3-month-long
study. The Asthma Control Test scores obtained from the medical records of 57 children were used to validate the asthma control
levels calculated using the Digital Phenotype Scores.
Results: At the cohort level, we found asthma was very poorly controlled in 37% (30/82) of the children, not well controlled
in 26% (21/82), and well controlled in 38% (31/82). Among the very poorly controlled children (n=30), we found 30% (9/30)
were highly compliant toward their controller medication intake—suggesting a re-evaluation for change in medication or
dosage—whereas 50% (15/30) were poorly compliant and candidates for a more timely intervention to improve compliance to
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mitigate their situation. We observed a negative Kendall Tau correlation between Asthma Control Test scores and Digital Phenotype
Score as −0.509 (P<.01).
Conclusions: kHealth kit is suitable for the collection of clinically relevant information from pediatric patients. Furthermore,
Digital Phenotype Score and Controller Compliance Score, computed based on the continuous digital monitoring, provide the
clinician with timely and detailed evidence of a child’s asthma-related condition when compared with the Asthma Control Test
scores taken infrequently during clinic visits.
(JMIR Pediatr Parent 2018;1(2):e11988)   doi:10.2196/11988
KEYWORDS
digital phenotype; actionable insights; asthma control level; asthma control test; digital phenotype score; controller compliance
score; mobile health
Introduction
Asthma is the second most common chronic disease in the
pediatric population. It incurred a total annual direct health care
cost of more than US $80 billion dollars burdening the US
economy [1]. As of 2016, more than 26 million Americans have
been diagnosed with asthma, of which 8.3% are children [2].
Asthma is a multifactorial disease, manifesting many symptoms,
which reduce the quality of life. The onset of asthma and the
factors that affect its severity and control level vary. Asthma
can affect a child’s physical and mental well-being. It can lead
to reduced activity, missed school days, difficulty in
concentrating, feeling isolated from peers, and in extreme cases,
emergency room visits, ultimately impacting long-term
academic, economic, and physical growth [3]. As such, parents
want to know how well controlled their child’s asthma is on a
regular basis, so that they, with the help of the clinician, can
better plan and manage their child’s care protocol.
Asthma patients are usually given an asthma action plan to deal
with asthma symptoms and a detailed education about triggers
and the importance of compliance. It would be helpful for the
parent and the clinician to receive information about the child’s
adherence to care protocol and exposure to factors that can
exacerbate the child’s asthma in a timely manner. We built the
kHealth system consisting of kHealth kit, kHealth cloud, and
kHealth Dashboard; adapted it for continuous and
comprehensive monitoring of a child’s symptoms, activity, sleep
pattern, potential environmental triggers, and medication
compliance; and derived insights to help manage asthma.
The kHealth kit consists of a mobile app, provided on an
Android tablet, that asks timely and contextually relevant
questions related to asthma symptoms, medication intake,
reduced activity because of symptoms, and nighttime
awakenings; a Fitbit to monitor activity and sleep; a Microlife
Peak Flow Meter to monitor the peak expiratory flow and forced
exhaled volume in 1 second; and a Foobot to monitor indoor
air quality. The kHealth cloud stores personal health data and
environmental data collected using Web services. The kHealth
Dashboard interactively visualizes the collected data. In the
contemporary clinical protocol, the most relevant information
will likely come from an Asthma Control Test (ACT) that is
administered during the child’s clinic appointment. The ACT
score is a recapitulation of the past 4 weeks of the child’s health
condition; there is considerable concern about its ability to
provide a clear picture of the child’s current health condition
[4,5]. Our kHealth system seeks to remedy this limitation by
embodying the digital phenotype.
The term digital phenotype refers to moment-by-moment
quantification of the individual-level human phenotype in situ
using data from personal digital devices, in particular, mobile
phones [6]. The data can be collected either by the active
involvement of a user, referred to as active sensing, or
automatically and nonintrusively using sensors, referred to as
passive sensing [7]. Digital phenotype in our study is the data
collected through active and passive sensing of a child, resulting
from the interaction of the child with the environment and
medication using the kHealth kit. Previous studies have reported
inaccuracies in a child’s self-reporting (in surveys, questionnaire,
etc) at the clinic [8,9]. Our kHealth system overcomes this
limitation by allowing 24/7 continuous and objective monitoring
of a child. Digital phenotype obtained can help the clinician
better diagnose, monitor, and manage asthma [6,10].
In this study, we focus on the cohort-level analysis of the data
collected from 95 asthmatic children using the kHealth app. To
abstract the digital phenotype in a form that is both accessible
and can serve as a proxy for the current practice, we define a
Digital Phenotype Score (DPS) and Controller Compliance
Score (CCS). DPS and CCS are based on the comprehensive
physical, environmental, activity, symptomatic, and medication
intake data collected from the kHealth system and form the basis
for actionable insights. For instance, unlike an ACT score, DPS
and CCS together can help the parent and the clinician to
intervene, improve the care protocol, change the medication
dosage, and take preventative measures as needed—such as
avoiding the outdoors and the use of an air filter or dehumidifier
in a timely manner.
Methods
Study Recruitment
Study participants were recruited from children (within the age
group of 5-17 years) diagnosed with asthma by an asthma
specialist at Dayton Children’s Hospital (DCH). Study
coordinator approached the parents of asthma patients seeking
treatment at DCH. The parent, along with the child, consented
to participate in our study. The parent provides the consent, and
the child provides an assent by signing a consent form to take
part in our study and giving permission to obtain their medical
details from the electronic medical records (EMRs). The
recruitment for the study is random, with the only prerequisite
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of suffering from asthma. The types of asthma, such as
nonpersistent, persistent, exercise-induced, and
nonexercise-induced, are not taken into account. A total of 100
study participants, along with a parent or guardian, consented
to the ongoing study during December 2016 until July 2018. A
total of 95 children of the 100 completed the study, with 5
children still collecting data at the time writing of this study.
The child and the parent were given an option to participate
either in a 1-month (n=70) or 3-month (n=25) study. The
participants who completed the 1- and 3-month study were given
an incentive of $50 and $100 gift cards, respectively. Figure 1
describes the study recruitment. Except for the duration of
participation, all other aspects of the participants were identical.
Each consenting participant was given a demonstration of all
the components of the kHealth kit with access to a user guide
and tutorial video on the tablet to make it accessible to both the
child and the parent. In case of any trouble encountered during
the study participation, the contact information of the nurse
practitioner was provided to the parent. In case of technical
difficulties, contact information of the kHealth team was
provided in the user guide to telephonically resolve the issue
while keeping the identity of the participant anonymized.
Study Design
This is an observational longitudinal study involving
collaboration among researchers from Kno.e.sis—an Ohio
Center of Excellence for BioHealth Innovations at Wright State
University and DCH, the latter consisting of a clinician and a
nurse coordinator. The study was approved by the DCH
institutional review board (IRB). The study uses readily
available sensors and widely used technologies. The study
comprises 30 kits to allow parallel participations of up to 30
children.
Study Kit
kHealth
The kHealth system comprises a kHealth kit, kHealth cloud,
and kHealth Dashboard.
kHealth Kit
A kHealth kit, as shown in Figure 2 (more information can be
found in Multimedia Appendix 1), consists of an Android tablet
hosting kHealth app and a set of sensors (Fitbit, Foobot, and
Microlife Peak Flow Meter), which are used by the child.
Sections below provide a description of all the sensors and the
type of data collected from them. The data are collected using
the active and passive sensing techniques. Active sensing refers
to the data collection where a child (or a parent) has to actively
interact with the technology (eg, answering questions after
invoking a mobile app). Passive sensing refers to the data
collected without active human interaction with the technology
(eg, Foobot [11] sensor in a room automatically collects the
indoor air quality data).
Figure 1. Study recruitment detail. ACT: Asthma Control Test; DPS-T: Digital Phenotype Score calculated using Total Symptom Score.
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Figure 2. kHealth System.
Table 1. kHealth app questionnaire.
Multiple-choice optionskHealth app questions
Cough, wheeze, chest tightness, hard and fast breathing, nose opens wide,
cannot talk in full sentences, others
Are you currently experiencing any of the asthma-related symptoms below?
1, 2, 3, 4, 5, 6+How many times did you take albuterol inhaler today because of asthma
symptoms?
Yes, noHave you had a wheeze, chest tightness, or asthma-related cough today?
None, a little, most of the day, at least half of the dayHow much did asthma or asthma symptoms limit your activity today?
Yes, noDid you take albuterol last night because of a cough or wheeze?
Yes, noDid you wake up with a cough or wheeze last night?
Yes, noRescue medication question. For example, did you take albuterol today?
Yes, noController medication question. For example, did you take Dulera today?
kHealth App
The kHealth app was built on the widely used Android platform
[12]. The app was designed in consultation with the clinician,
tested with trial patients, and iteratively refined before reaching
the current version used in this study [13]. The app asks
questions similar to the ACT. The app captures symptoms,
medication intake, and activity limitation because of asthma
symptoms and nighttime awakenings using a questionnaire that
the child is expected to answer twice a day. The app was
customized for every child, such as the medication (rescue and
controller) information for every child was taken from the
EMRs, and the medication intake questions were asked for the
prescribed medication only. Table 1 below shows the kHealth
app questionnaire.
kHealth Cloud
The data collected from the kHealth kit are synced in real time
with Firebase, a Google cloud storage. Firebase provides active
data listening for the client-side, which offers data persistence
over a network failure and re-syncs to the cloud when the
network is restored. The kHealth app uses SQLite as the primary
data storage and Firebase as the secondary data storage. Data
from Firebase are available to Kno.e.sis researchers and
clinicians for real-time analysis. For securing remote data,
Firebase provides a set of real-time database rules and user
authentication that allow data access control on a per-user basis.
Moreover, it is built on the Google Cloud Platform, sharing the
same level of data security [14].
kHealth Dashboard
kHealth Dashboard as shown in Figure 3 is a cloud-based
platform that integrates and visualizes multimodal data from
the kHealth kit [15] (A demo video of the kHealth Dashboard
can be found by accessing the link provided in Multimedia
Appendix 1). It provides an alternative to the traditional episodic
clinician-centric health care by supporting real-time monitoring
of a child’s health condition [16]. It is a step toward exploring
issues such as the following: Can we predict asthma attacks
based on the data collected from the child? Can we understand
the causal relationship between symptoms and possible triggers
or factors responsible for them? kHealth Dashboard allows us
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to visually explore the correlations between the child’s recorded
readings about their condition and environmental data. It also
gathers empirical evidence to analyze and monitor disease
progression as well as help manage asthma.
Study Variables
Symptom Score
Symptom score (SS) is the measure of the symptoms (cough,
wheeze, chest tightness, nose open wide, and hard and fast
breathing) experienced by the child during the study period.
The study period is defined as the number of days the child took
a kHealth app reading. The clinician can use the SS measure to
get real-time insight into the child’s condition, such as changes
in symptoms because of weather or outdoor condition. We used
2 different metrics to calculate a child’s SS based on (1) the
total number of symptoms experienced by the child during the
study period (the total number of symptoms experienced is the
same as the total number of symptom questions answered in
affirmative per day) and (2) the total number of days the child
experienced some symptom during the study period. We define
Total Symptom Score (TSS) as the average number of symptoms
experienced by the child during the study period. We define
Partial Symptom Score (PSS) as the fraction of the number of
days the child experienced symptom during the study period.
Total Symptom Score (TSS) = Number of symptoms
experienced by the child/Study period
Partial Symptom Score (PSS) = Number of days the
children experienced symptoms/Study period
Rescue Score
The kHealth app collects data on the intake of the rescue
medication (short-acting bronchodilators) by asking questions
such as Did you take albuterol today? We define Rescue Score
(RS) as the number of times the child took the rescue medication
during the study period. Usually, children take rescue medication
to mitigate or prevent the symptoms.
Rescue Score (RS)= Number of rescue medication
intake by the child during the study period/Study
period
Controller Compliance Score
The kHealth app asks questions (eg, Did you take DULERA
today?) about the intake of the controller medication (long-term
control medication). Each child is prescribed a controller
medication, which they are supposed to take at least once a day.
Thus, the CCS is defined as the fraction of the number of days
the child took the controller medication during the study period.
Controller Compliance Score (CSS) = Number of
controller medication intake by the child during the
study period/Study period
The percentage of children in the well-controlled category
increases with the increasing CCS, as shown in Figure 4. The
more compliant children are toward their medication, the better
controlled is their asthma. Table 2 describes the controller
medication compliance threshold. We chose a threshold of 70%.
For example, if the child took her/his medication at least 70%
of the prescribed duration during the study period (for 1 month
[30 days] minimum 21 days and for 3 months [90 days]
minimum 63 days), then the corresponding CCS≥0.70 and is
the child is classified as highly compliant.
Figure 3. kHealth Dashboard Visualizing the Data.
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Figure 4. The variation of the percentage of children in the different asthma control level with the Controller Compliance Score.
Table 2. Controller Compliance Score thresholds.
Controller Compliance Score (CCS)Compliance
CCS≥0.70Highly compliant
0.30≤CCS<0.70Well compliant
CCS<0.30Poorly compliant
Activity Score
The Activity Score (AcS) is the number of days the child had
restricted activity during the study period. The kHealth app asks
a multiple-choice question: How much did asthma symptoms
limit your activity today? with 4 options: none, a little, half of
the day, and most of the day. The options are given a weight on
a scale of 0-3, respectively.
Activity Score (AcS) = Summing over the days in the
study period (activity restriction presence option
weight)/Study period
Awakening Score
The Awakening Score (AwS) is the number of nights the child
woke up because of asthma symptoms during the study period.
The kHealth app asks a multiple-choice question: Did you wake
up with wheeze, cough, or any asthma-related symptoms?
Awakening Score (AwS) = Number of nights the child
woke up with asthma symptoms during the study
period/Study period
Asthma Control Test Score
ACT is a short multiple-choice questionnaire consisting of 5
questions: about a child’s symptoms, nighttime awakenings
because of symptoms, number of days the child missed school
because of symptoms, intake of rescue medication, and the
child’s rating about their asthma control in the past 4 weeks.
Each question is given a score of 1-5, with 1 being the worst
and 5 being the best. The ACT score is calculated by adding
the scores for each question. Its score helps the clinician classify
the child’s asthma as well controlled, not well controlled, or
very poorly controlled [17]. The ACT score based asthma
control level label varies with the age group. For children less
than 12 years, if the ACT score is ≤12, the child’s asthma is
very poorly controlled. If the ACT score is ≥13 and ≤19, the
asthma is not well controlled, and if the ACT score is ≥20, the
asthma is well controlled. For the children aged ≥12 years, if
the ACT score is ≤15, the child’s asthma is very poorly
controlled. If the ACT score is ≥16 and ≤19, the asthma is not
well controlled, and if the ACT score is ≥20, the asthma is well
controlled.
Digital Phenotype Score
Digital Phenotype Score Total (DPS-T) = Total
Symptom Score + Rescue Score + Activity Score +
Awakening Score
Digital Phenotype Score Partial (DPS-P)= Partial
Symptom Score + Rescue Score + Activity Score
+Awakening Score
The DPSs (DPS-T and DPS-P, discussed below) capture an
aggregate of each of the contributing digital phenotypes that
impact the child’s health. This is in the same vein as ACT, which
tries to quantify the child’s asthma control based on responses
to the 5 asthma condition–related questions and Patient Health
Questionnaire-9 (PHQ-9), which tries to quantify patients’
depression severity based on their responses to the 9 mental
health condition–related questions [18,19]. The DPSs are a
digital measure of the quality of life of the child appropriate for
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the kHealth context and can be used as a succinct proxy to
determine the control level. We try to capture the intuition that
the higher the manifestation of asthma signs, the worse the
control. The more occurrences of symptoms, increased intake
of rescue medication, restriction of daily activities and nighttime
awakenings, and the worse is the child feeling, the poorer is the
asthma control. We propose to define the scores to reflect the
cumulative effect of various negative factors impacting a child’s
health and its manifestation, as measured by symptoms such as
cough and wheeze, reduced physical activity, nighttime
awakenings, and intake of rescue medication, either to remedy
symptoms or to prevent them. Specifically, we consider 2
different alternatives for computing the score each with its own
pros and cons: (1) DPS-T to capture the total number of asthma
episodes by summing the TSS, RS, AcS, and AwS, which we
regard as a fine-grained reflection of the child’s suffering, and
(2) DPS-P that substitutes the TSS with a PSS in DPS-T (ie,
DPS-P=DPS-T − TSS + PSS) to better match the ACT scoring
approach to determine the control level, for fair comparison and
validation with respect to the current practice. Similar to the
ACT scoring, our approximation does not have differential
weighing of symptoms (such as cough < wheeze < chest
tightness). Although this may be adequate to obtain a
coarse-grained classification for control level, it may not truly
reflect the relative quality of life enjoyed by the child faithfully.
For instance, a child having 10 coughs each day for 2 days may
be better off than 10 coughs over 3 days. DPS-T better captures
this intuition than DPS-P. However, ACT scores, DPS-T, and
DPS-P do not satisfactorily capture the fact that someone having
wheezing, shortness of breath, and chest tightness on a day may
be significantly worse off than someone coughing several times
a day. In fact, the former may lead to an asthma attack, even
requiring an emergency hospital visit compared with the latter.
In this study, we evaluate DPS-T and DPS-P as an approximate
measure of the asthma-related health condition of the child.
The National Heart Lung Blood Institute (NHLBI) provides a
guideline to classify the child’s asthma control level as very
poorly controlled, not well controlled, and well controlled. We
used the NHLBI guidelines and the data collected from the
kHealth app to determine the child's control level by developing
a comparable threshold for DPS-P and DPS-T.
Using the NHLBI guidelines given in Table 3 [20], we have
developed thresholds for DPS (DPS-P and DPS-T) as shown in
Table 4 (eg, if the DPS≥1, then the child’s asthma is very poorly
controlled). The thresholds for the 3 control levels have been
chosen to make the DPS-P and ACT scores comparable when
they are available over the same period. The control levels
obtained based on DPS-T using the same thresholds seem to be
relatively pessimistic, but in reality, they have the potential to
capture the child’s reaction to asthma triggers over the day at a
fine-grained level.
Table 3. Modified National Heart Lung Blood Institute asthma control level classification guide (given by National Heart Lung Blood Institute).
Level of asthma controlAge in yearsComponent of control
Very poorly controlledNot well controlledWell controlled
Impairment
Throughout the day>2 days/week or multiple
times on ≤2 days/week
≤2 days/week but ≤1 time a
day
0-11Symptoms
Throughout the day>2 days/week≤2 days/week≥12
>1 time a week>1 time a month≤1 time a month0-4Nighttime awakenings
≥2 times a week≥2 times a month≤1 time a month5-11
≥4 times a week1-3 times a week≤2 times a month≥12
Extremely limitedSome limitationNoneAllInterference with normal activity
Several times per day>2 days/week≤2 days/weekAllRescue medication; use for symptoms
Table 4. The thresholds for the classification of asthma control levels for both Digital Phenotype Score calculated using Partial Symptom Score and
Digital Phenotype Score calculated using Total Symptom Score.
Digital Phenotype Score (DPS)Asthma control level
DPS≥1Very poorly controlled
0.28≤DPS<1Not well controlled
DPS<0.28Well controlled
Data Availability
The study took comprehensive design- and technology-supported
steps to ensure Health Insurance Portability and Accountability
Act (HIPAA) compliance, privacy preservation, and data
security. For example, each consented child was given a
kHealth-ID by the nurse coordinator and retained so that child
identifiable information did not leave the hospital clinic [21].
Throughout the data collection, only the deidentified data were
made available for analysis by the kHealth system. A child’s
real identity was not recorded, and any data exchange between
DCH and other researchers ensured that the child’s identity
information did not leave DCH. The data used for the study
cannot be made publicly available because of HIPAA and other
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restrictions imposed by the approved IRB protocol. The dataset
is accessible only to the clinician and the researchers involved
in the study. Furthermore, it is available to the researchers only
in anonymized form. All team members have completed relevant
Collaborative Institutional Training Initiative program courses.
Data Analysis
We performed a descriptive analysis of the data with IBM SPSS
Statistics version 24 (IBM Corporation). We removed 13
children from our analysis who had data for less than 7 days to
follow the NHLBI guideline, which requires a minimum of a
week’s data to determine the child’s asthma control level [20].
This study presents an analysis of 82 children reporting data for
more than 7 days. ACT scores were available from the EMRs
for 57 of these children and were used for validation of the
asthma control levels, calculated using the DPSs. We used
Kendall Tau correlation metric to analyze the concordance
between the asthma control level labeled using ACT scores and
DPSs.
Results
The average compliance of the kHealth kit was 75% (range:
9-100, SD=23). Of the children in our study cohort, 66% (54/82)
were found to be highly compliant, 31% (25/82) were well
compliant, and 4% (3/82) were found to be poorly compliant
toward taking the kHealth app reading. The highly compliant
and well compliant are defined using the kHealth app and taking
a reading for at least 70% and 50%, respectively, of the study
period. We classified the 82 children involved in our study into
their asthma control level using the DPS-P and DPS-T. Using
DPS-P, 30.5% of the children were classified as very poorly
controlled, 26.8% as not well controlled, and 42.7% as well
controlled. DPS-P classification (using scoring and threshold)
adapts the ACT approach in the context of kHealth app. On the
basis of DPS-T, 37% of the children were classified as very
poorly controlled, 26% as not well controlled, and 38% as well
controlled. Effectively, DPS-T classified a higher number of
children as very poorly controlled or not well controlled as
compared with DPS-P.
We used ACT scores recorded in the EMRs to understand how
it corresponds to our classification based on the 2 DPS scales.
ACT scores were available for 57 children of the 82 children
who qualified for detailed evaluation. Tables 5 and 6 provide
classification details using DPS-T and DPS-P based on adapted
thresholds.
Table 5. The relationship between Asthma Control Test and the 2 versions of the Digital Phenotype Scores (N=57).
DPS-Tc, n (%)DPS-Pb, n (%)ACTa score, n (%)Asthma control labels
23 (40)20 (35)9 (16)Very poorly controlled
16 (28)15 (26)17 (30)Not well controlled
18 (32)22 (39)31 (54)Well controlled
aACT: Asthma Control Test.
bDPS-P: Digital Phenotype Score calculated using Partial Symptom Score.
cDPS-T: Digital Phenotype Score calculated using Total Symptom Score.
Table 6. Asthma Control Test and Digital Phenotype–based classification (N=57) where VPC is very poorly controlled asthma, NWC is not well
controlled asthma, and WC is well controlled asthma. .
Children classified based on DPS-T,c nChildren classified based on DPS-P,b nChildren classified based on
ACTa score, n
Asthma control labels
VPC=8VPC=79Very poorly controlled (VPC)
NWC=0NWC=1
WC=1WC=1
VPC=13VPC=1117Not well controlled (NWC)
NWC=3NWC=4
WC=1WC=2
VPC=2VPC=231Well controlled (WC)
NWC=12NWC=10
WC=17WC=19
aACT: Asthma Control Test.
bDPS-P: Digital Phenotype Score calculated using Partial Symptom Score.
cDPS-T: Digital Phenotype Score calculated using Total Symptom Score.
As seen in Table 7, the DPS-P scale correctly classifies 7 out
of 9 children as very poorly controlled. There was only 1 child
with an ACT score of 11 (which is very poorly controlled) who
was classified as well controlled according to DPS-P (=0.19)
JMIR Pediatr Parent 2018 | vol. 1 | iss. 2 | e11988 | p.8http://pediatrics.jmir.org/2018/2/e11988/
(page number not for citation purposes)
Jaimini et alJMIR PEDIATRICS AND PARENTING
XSL•FO
RenderX
and not well controlled according to DPS-T (=0.39). We
observed 2 children with the same DPS-P score of 1.33 (very
poorly controlled), but they had 2 different ACT scores of 15
and 19, respectively, but both imply not well controlled.
Although their DPS-P was the same, their DPS-T are 1.43 and
2.32, respectively, showing that the second child’s asthma
condition is worse than the first one. We observed 2 children
with DPS-P of 0.74 and 0.72, respectively, both not well
controlled according to DPS-P criteria. According to their ACT,
the same 2 children were classified as very poorly controlled
(ACT score=13) and well controlled (ACT score=24).
Furthermore, their DPS-T was 1.70 and 0.76, respectively. The
latter’s scores are consistent with the DPS-P but also show that
the first child is relatively worse off than the second child. Note
also that differently classified children in the 3 categories were
deployed in the allergy season, accounting for a higher SS during
the allergy season, which was not captured by the ACT. Thus,
DPS has the potential to provide more contemporary and timely
gauge of a child’s asthma control.
Next, we provide further observations based on DPS-T and
CCS. We observed that 50% of very poorly controlled children
were poorly compliant, 20% well compliant, and 30% highly
compliant. In the not well-controlled children cohort, 42.9%
were poorly compliant, 28.6% well compliant, and 28.6% highly
compliant. The well controlled children were 48.4% poorly
compliant, 16.1% well compliant, and 35.5% highly compliant.
Figure 5 shows the distribution of ACT score and DPS-P. Figure
6 shows the distribution of ACT score and DPS-T.
To better quantify the relationship between the distribution of
ACT scores and the DPS, we used Kendall Tau correlation
metric to analyze the concordance between them [22,23]. We
observed a negative correlation between ACT scores with both
DPS-T and DPS-P and calculated them as −0.509** and
−0.509**, respectively, (P<.01). The negative correlation
accords well with that the fact the ACT scores and DPSs are
inversely related. Unsurprisingly, we also observed a positive
correlation between DPS-T and DPS-P as 0.921** (P<.01).
We also explored potential reasons for the varying asthma
control by analyzing CCS, reflecting how well a child follows
the asthma management protocol in terms of controller
medication intake. We observed that 47.6% of the study
participants were poorly compliant (according to CCS), 20.7%
were well compliant, and 31.7% were highly compliant toward
their controller medication use.
Figure 5. Distribution of Asthma Control Test score and Digital Phenotype Score calculated using Partial Symptom Score across the study population.
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Figure 6. Distribution of Asthma Control Test Score and Digital Phenotype Score calculated using Total Symptom Score across the study population.
Discussion
Principal Findings
Suboptimal adherence to asthma therapy in children has been
shown to result in poor disease control and increased
hospitalization. Our study highlights this important issue,
demonstrating a 50% compliance with controller medication in
a cohort of children under the care of asthma specialists, which
can be improved. In addition, almost 66% compliance with
kHealth kit was achieved in this cohort. The 66% compliance
with kHealth kit in this cohort appears to be highly encouraging,
especially given the relative complexity of the kit (eg, need to
connect with Wi-Fi or use a dongle) and the fact that DCH
generally serves families in the medium to lower socioeconomic
measures, including inner city. The kit compliance is the
measure of the number of days the child took the kHealth kit
reading during the deployment duration (1 or 3 months). This
shows the potential to improve adherence by motivating children
and parents. Several studies have demonstrated an increased
adherence when data from electronic monitoring were shared
with participants [9]. In children with asthma, an improvement
in the use of preventive medication has been demonstrated when
feedback was provided at each clinic visit [24]. The clinicians
and researchers can be involved in patient-led and
patient-centered digital health design [25]. It can encourage
patients to share their data with their clinician or the researchers
involved. It can be used to learn about the patient’s online
networks and educate the patient by connecting with them and
strengthening the network. The kHealth study offers an
intervention for improving asthma control level as determined
using the DPS. It demonstrates an opportunity for timely
identification of children who are not well controlled or poorly
controlled, and on the basis of their compliance, offer guidance
for further intervention. For instance, for poorly compliant
children, the parent or guardian can provide timely reminders
to improve compliance for taking controller medication. In fact,
this is also an opportunity to automatically generate friendly
and timely reminders in a later version of our kHealth app, IRB
approval permitting. For well complaint children, the clinician
may decide to reevaluate medication and its dosage.
Several reasons can account for the discrepancy between
assessments based on the ACT score and the DPS-P/DPS-T.
The primary reason seems to be that the ACT was administered
before the deployment of the kHealth kit and, in a number of
cases, at the onset of the allergy season. Hence, there can be a
mismatch between the relatively good asthma control level
during trigger-free environment as compared with the asthma
control level during allergy season. Furthermore, these same
children are unlikely to return for a follow-up appointment
(because their asthma is well controlled according to ACT and
as dictated by the current practice are not required to take ACT
at the end of the study period), and hence, we have no way to
obtain ACT scores specifically summarizing the child’s
condition during the allergy period for these specific study data.
In addition, the ACT scores are based on child’s self-reporting
and memory of episodes of past 4 weeks, running the risk of
missing out on the fine-grained details that the kHealth can
capture reliably and effortlessly (with its passive components).
The kHealth app asks questions similar to ACT twice a day,
providing a detailed day-to-day insight into the child’s condition.
ACT scores provide an abstract, subjective, and cumulative
picture of the child, whereas the kHealth app additionally
provides an objective and a more granular insight into the child’s
environment, activities, medication intake, and so on. Also note
JMIR Pediatr Parent 2018 | vol. 1 | iss. 2 | e11988 | p.10http://pediatrics.jmir.org/2018/2/e11988/
(page number not for citation purposes)
Jaimini et alJMIR PEDIATRICS AND PARENTING
XSL•FO
RenderX
that ACT questions abstract away occurrences of a number of
symptoms per day by considering only the number of days the
symptoms appear, whereas DPS-T captures such additional
fine-grained detail. The DPS-P was developed to approximate
and generalize information sought in ACT questionnaire. Thus,
DPS-T is able to distinguish between 2 children who experience
a different number of symptoms every day that DPS-P is not
sensitive to. As with ACT, we still do not distinguish the
acuteness of different symptoms with respect to asthma. Using
the DPS-based control levels and CCS, we can provide
actionable insights (interventional steps) devised in consultation
with our clinician partner as described in Table 7.
Limitations
Children were enrolled on a first-come-first-serve basis, as the
study was designed to demonstrate (1) feasibility of the kHealth
system approach involving acceptability and usability, (2)
robustness of the kHealth kit, quality, and consistency of
measurements that provide clinically relevant data not currently
available to the clinician (including assessing the relevance of
patient-generated data and environmental data), and (3)
maximize recruitment. Specifically, we had not planned the
kHealth kit deployment for a child to coincide with their asthma
exacerbation season or only in allergy season. We also did not
deploy the kit for a longer duration (ie, half a year or year round)
using the current IRB-approved protocol so as to straddle both
nonallergy and allergy seasons to contrast the behaviors on
normal days from allergy exposure days.
Several future options can further increase compliance, such as
(1) use of more integrated sensors if the cost is acceptable [26],
(2) higher monetary incentive for participation, (3) nonmonetary
incentive including the clinician’s feedback during a follow-up
consult, and (4) more close-up monitoring such as nurse
coordinators calling the parent of the children who are
delinquent in using the app during the early days of the
participation.
Table 7. Actionable insight using Digital Phenotype Score and Controller Compliance Score.
Well controlledNot well controlledVery poorly controlledController compliance
Maintain therapy. Consider chang-
ing the medication or its dosage.
Increase the medication dosage or
change/add medication. Identify
environmental triggers for mitiga-
tion.
Increase the medication dosage or
change/add medication. Identify
environmental triggers for mitiga-
tion.
Highly compliant
Maintain therapy. Consider chang-
ing the medication or its dosage.
Increase the medication dosage or
add medications; provide appropri-
ate preventative suggestions.
Increase the medication dosage or
add medications; provide appropri-
ate preventative suggestions.
Well compliant
Reassess diagnosis and modify
therapy.
Identify barriers to adherence and
intervene.
Identify barriers to adherence and
intervene.
Poorly compliant
Children were given ACT before kHealth kit deployment, but
the ACT was not repeated after the kHealth study period.
Moreover, 57 of the 82 cohorts had recorded and available ACT
scores. These factors made it difficult to more comprehensively
validate our diagnosis based on the digital phenotype approach
(DPS-P and DPS-T) against the ACT. Our extensive use of
sensors and technology to collect a large variety of data,
although novel, had resulted in initial challenges for reliable
collection of data, ease of deployment, and use with implications
on child compliance. To address these issues, the app underwent
multiple design iterations to improve the data retention, usability
in terms of intended functionality and connectivity, compliance,
and reliability on passive sensing. In particular, 1 sensor used
for nitric oxide measurement during the initial trial was removed
by the manufacturer from the market and was replaced by the
peak flow meter. The accuracy and usefulness of a number of
sensors were assessed before starting the study [11].
Conclusions
We have shown that the kHealth app is robust and reliable for
use by the pediatric patient and can provide meaningful
information to a clinician. We were able to clearly determine,
at the cohort level, the relative distribution of children with
different ACT scores into different control-level classes, as
classified by digital phenotype approach. We also have evidence
that tracking the children can not only shed light on their health
condition but also provide actionable insight based on their
adherence to asthma care plan. Specifically, we expect the digital
phenotype and compliance data to be able to provide clinicians
with detailed evidence much more transparently and in a more
timely manner than the ACT. kHeath asthma was an
observational study and lacked an intervention arm. Future trials
assessing the impact of feedback derived from digital monitoring
on adherence with asthma therapy in children are needed.
Future Work
We plan to conduct a follow-up study that evaluates children
over longer periods, covering both allergy and nonallergy
seasons. We would like to identify factors affecting asthma at
a personalized level as a means to detect the triggers that cause
the asthma-related symptoms, monitor the control level, and
predict the potential for asthma exacerbation to minimize
emergency room visits. This can also help us educate parents
and children to improve asthma management and to empower
clinicians via an evidence-based approach to obtain better
outcomes for each child. We expect the digital phenotype
approach and the monitoring of controller medication
compliance developed here to be useful in modifying the care
protocol and will use them to design a follow-up study as an
interventional step. At a broader level, we seek to enhance health
care and chronic disease management by aggregating, analyzing,
and personalizing the use of relevant physical, cyber, and social
data obtained from wearables, sensors, mobile apps, EMRs,
Web-based information, and social media. We also seek to
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develop tailored health management strategies suitable for all
ages and at different levels, including self-monitoring,
self-appraisal, self-management, intervention, prediction, and
tracking disease progression, as identified in our Augmented
Personalized Healthcare approach [27,28]. Ultimately, we expect
evidence-based disease management to help in reducing the
overall cost of care while simultaneously improving quality of
life.
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ACT: Asthma Control Test
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AwS: Awakening Score
CCS: Controller Compliance Score
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DPS: Digital Phenotype Score
DPS-T: Digital Phenotype Score calculated using Total Symptom Score
DPS-P: Digital Phenotype Score calculated using Partial Symptom Score
EMR: electronic medical record
HIPAA: Health Insurance Portability and Accountability Act
IRB: institutional review board
NHLBI: National Heart Lung Blood Institute
PSS: Partial Symptom Score
RS: Rescue Score
SS: symptom score
TSS: Total Symptom Score
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